Polimorfismo C358A de la enzima «amida hidrolasa de ácidos grasos» y los niveles de adipocitoquinas en obesos mórbidos

Endocrinología y Nutrición - Tập 57 - Trang 54-59 - 2010
Daniel A. De Luis1, Manuel González Sagrado1, Rocío Aller1, Olatz Izaola1, Rosa Conde1, Enrique Romero1
1Instituto de Endocrinología y Nutrición, Unidad de Investigación, Facultad de Medicina, Hospital Río Hortega, Universidad de Valladolid (RETICEF 056/0013), Valladolid, España

Tài liệu tham khảo

Aranceta, 1998, Prevalencia de la obesidad en España: estudio SEEDO 97, Med Clin (Barc), 111, 441 Matsuzawa, 2005, Adipocytokines: Emerging therapeutic targets, Curr Athero Rep, 7, 58, 10.1007/s11883-005-0076-3 Ameri, 1999, The effects of cannabinnoids on the brain, Prog Neurobiol, 58, 315, 10.1016/S0301-0082(98)00087-2 Brown, 2002, Cloning and molecular characterization of the rat CB2 cannabinoid receptor, Bioch Biophys Acta, 1576, 255 Fride, 2002, Endocannabinoids in the central nervous system an overview, Pros Leuk Essent Fatty Acids, 66, 221, 10.1054/plef.2001.0360 Deustch, 2002, The fatty acid amide hydrolase (FAAH) 1, Prostaglandins Leukot Essent Fatty Acids, 66, 201, 10.1054/plef.2001.0358 Lichtman, 2002, Pharmacological activity of fatty acid amides is regulated, but not mediated, by fatty acid amide hydrolase in vivo, Pharmacol Exp Ther, 302, 73, 10.1124/jpet.302.1.73 Sipe, 2002, A Missense mutation in human fatty acid amide hydroxylase associated with problem drug abuse, Proc Natl Acad Sci USA, 99, 8394, 10.1073/pnas.082235799 Sipe, 2005, Overweight and obesity associated with a missense polymorphism ain fatty acd amide hydrolase (FAAH), Inte J Obes, 29, 755, 10.1038/sj.ijo.0802954 Monteleone, 2008, The CDNA 385 C to A missense polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) os associated with overweight/obesity but not with binge eating disorder in overweight/obese women, Psychoneuroendo, 33, 546, 10.1016/j.psyneuen.2008.01.004 Jensen, 2007, The functional pro129Thr variant of the FAAH gene is not associated with various fat accumulation phenotypes ina a population-based cohort of 5801 whites, J Mol Med, 85, 445, 10.1007/s00109-006-0139-0 Harrold, 2003, The cannabinoid system: a role in both the homeostatic and hedonic control o eating?, Br J Nutr, 90, 729, 10.1079/BJN2003942 Mathews, 1985, Homesotasis model assessment: insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man, Diabetologia, 28, 412, 10.1007/BF00280883 Feurer, 1986, Bedside measurement of resting energy expenditure and respiratory quotient via indirect calorimetry, Nutr Clin Pract, 1, 43, 10.1177/088453368600100106 Pichard, 1993, Bioimpedance analysis: an improved method for nutritional follow up, Clin Res, 41, 53 Mataix J, Mañas M. Tablas de composición de alimentos españoles. Ed: University of Granada, 2003. Papazoglou, 2008, The FAAH Pro129Thr polymorphism is not asociated with severe obesity in Greek Subjects, Horm Metab Res, 40, 907, 10.1055/s-0028-1087169 Egertova, 2003, Comparative analysis of FAAH and CB1 canabinoid receptor expression in the mouse brain: evidence of a widespread role for fatty acid amide hydrolase in regulation of endocannabinoid signalling, Neuroscience, 119, 481, 10.1016/S0306-4522(03)00145-3 Aberle, 2007, Genetic variation in two proteins of the endocannabinoid system and their influence on body mass index and metabolism under low fat diet, Horm Metab Res, 39, 395, 10.1055/s-2007-977694 Cota, 2003, Endogenous cannabinoid system as a modulator of food intake, Int J Obes Relat Metab Disor, 27, 289, 10.1038/sj.ijo.0802250